Ophthalmology · Roanoke, VA
NPI
1083972913
Since 2012
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
707 S Jefferson St
Roanoke, VA, 24016
Phone (540) 855-5100
Groups this clinician bills Medicare through
Medicare paid, 2024
$462K
5,912 services
Medicare patients, 2024
1,227
Average age 77
Drug cost, 2024
$991K
13,875 prescriptions
Company payments, 2025
$2,534
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tad D Schoedel was code 99214 (office e&m - established), 1,646 times for 904 patients. In total Tad D Schoedel billed 5,912 services in 52 codes, and Medicare paid $462K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,646 | 904 | $81.89 | $135K |
| 92083 Vision, Hearing, and Speech Services | Office | 1,411 | 931 | $43.13 | $61K |
| 92133 Computerized Ophthalmic Imaging | Office | 760 | 744 | $22.13 | $17K |
| 68841 Eye | Facility | 265 | 163 | $12.29 | $3,257 |
| 92136 Ultrasound - Nonspecific | Office | 254 | 169 | $28.33 | $7,197 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 218 | 204 | $11.73 | $2,556 |
| 66984 Cataract Surgery | Facility | 203 | 117 | $318.67 | $65K |
| 92014 Ophthalmological E&M | Office | 198 | 177 | $77.53 | $15K |
| 92020 Ophthalmological E&M | Office | 163 | 162 | $18.92 | $3,085 |
| 99204 Office E&M - New | Office | 150 | 150 | $108.15 | $16K |
| 76514 Ultrasound - Nonspecific | Office | 140 | 140 | $7.31 | $1,024 |
| 66821 Cataract Surgery | Facility | 83 | 62 | $210.12 | $17K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 62 | 54 | $170.42 | $11K |
| 65820 Fluid Flow and Drainage of Eye (Any Method) | Facility | 59 | 41 | $548.03 | $32K |
| 66988 Cataract Surgery | Facility | 46 | 27 | $251.88 | $12K |
By year: 2022 $471K for 5,178 services; 2023 $504K for 5,820 services; 2024 $462K for 5,912 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tad D Schoedel prescribed most often to Medicare patients was Latanoprost, with 4,277 prescriptions and refills. In total Tad D Schoedel wrote 13,875 Medicare prescriptions that cost $991K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 4,277 | 7,962 | 965 | $27K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 2,361 | 5,012 | 604 | $33K |
| Brimonidine Tartrate Generic | 1,542 | 2,784 | 365 | $25K |
| Prednisolone Acetate Generic | 800 | 862 | 288 | $25K |
| Dorzolamide Hcl Generic | 765 | 1,362 | 210 | $13K |
| Timolol Maleate Generic | 717 | 1,296 | 174 | $5,189 |
| Lumigan Bimatoprost | 652 | 931 | 127 | $232K |
| Rhopressa Netarsudil Mesylate | 375 | 510 | 89 | $159K |
| Ciprofloxacin Hcl Generic | 276 | 281 | 190 | $3,058 |
| Simbrinza Brinzolamide/Brimonidine Tart | 266 | 368 | 52 | $71K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 239 | 345 | 54 | $30K |
| Ketorolac Tromethamine Generic | 229 | 236 | 143 | $3,832 |
| Travoprost Generic | 216 | 362 | 49 | $28K |
| Combigan Brimonidine Tartrate/Timolol | 173 | 278 | 40 | $55K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 147 | 223 | 31 | $76K |
Brand drugs: 3,614 claims; generic drugs: 10,261 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tad D Schoedel $2,534 ($2,534 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $908.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.